Cargando…
Development of a novel universal immune receptor for antigen targeting: To Infinity and beyond
Chimeric antigen receptors (CARs) possess fixed specificity for a single antigen and require empirical testing in T cells. To address this, we have developed a novel, adaptable immune receptor strategy that allows for the rapid generation and testing of T cells of nearly infinite antigen specificity...
Autores principales: | Urbanska, Katarzyna, Powell, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429592/ https://www.ncbi.nlm.nih.gov/pubmed/22934280 http://dx.doi.org/10.4161/onci.19730 |
Ejemplares similares
-
CD123 AML targeting by chimeric antigen receptors: A novel magic bullet for AML therapeutics?
por: Tettamanti, Sarah, et al.
Publicado: (2014) -
Immune modulation by molecular cancer targets and targeted therapies: Rationale for novel combination strategies
por: Rossig, Claudia
Publicado: (2012) -
Antigen shedding into the circulation contributes to tumor immune escape
por: Höchst, Bastian, et al.
Publicado: (2012) -
Beyond DNA repair: the novel immunological potential of PARP inhibitors
por: Chabanon, Roman M., et al.
Publicado: (2019) -
Targeting mutagenesis in B cells: Phosphorylation goes beyond AID association
por: Mu, Yunxiang, et al.
Publicado: (2018)